Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)

NCT01699867 is registered in ClinicalTrials.gov with Diagnostic Photonics, Inc. as lead sponsor.

NCT NCT01699867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01699867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)
Lead sponsor
Diagnostic Photonics, Inc.
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
April 30, 2014
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer